Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 15.94 -1.91% -0.31
PTCT closed down 1.91 percent on Tuesday, December 12, 2017, on 60 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Down Down
See historical PTCT trend table...

Date Alert Name Type % Chg
Dec 12 200 DMA Support Bullish 0.00%
Dec 12 Bollinger Band Squeeze Range Contraction 0.00%
Dec 12 Wide Bands Range Expansion 0.00%
Dec 12 Down 3 Days in a Row Weakness 0.00%
Dec 11 Upper Bollinger Band Walk Other -1.91%
Dec 11 Bollinger Band Squeeze Range Contraction -1.91%
Dec 11 BB Squeeze + Upper Band Touch Range Contraction -1.91%
Dec 11 Wide Bands Range Expansion -1.91%
Dec 11 Overbought Stochastic Strength -1.91%
Dec 11 Upper Bollinger Band Touch Strength -1.91%

Older signals for PTCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Is PTCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.0
52 Week Low 8.12
Average Volume 1,029,587
200-Day Moving Average 15.8628
50-Day Moving Average 16.9684
20-Day Moving Average 15.9795
10-Day Moving Average 16.114
Average True Range 0.7432
ADX 15.89
+DI 18.16
-DI 25.74
Chandelier Exit (Long, 3 ATRs ) 14.7304
Chandelier Exit (Short, 3 ATRs ) 17.0996
Upper Bollinger Band 16.7853
Lower Bollinger Band 15.1737
Percent B (%b) 0.48
BandWidth 10.085422
MACD Line -0.1788
MACD Signal Line -0.2904
MACD Histogram 0.1116
Fundamentals Value
Market Cap 659.74 Million
Num Shares 41.4 Million
EPS -3.05
Price-to-Earnings (P/E) Ratio -5.23
Price-to-Sales 5.48
Price-to-Book 3.95
PEG Ratio 0.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.10
Resistance 3 (R3) 17.11 16.74 16.90
Resistance 2 (R2) 16.74 16.45 16.73 16.84
Resistance 1 (R1) 16.34 16.26 16.16 16.33 16.77
Pivot Point 15.97 15.97 15.88 15.96 15.97
Support 1 (S1) 15.57 15.68 15.39 15.56 15.11
Support 2 (S2) 15.20 15.49 15.19 15.04
Support 3 (S3) 14.80 15.20 14.98
Support 4 (S4) 14.79